GlassScriptPhysician profile
Susan M Zimmerman
NPI 1063444214
$217.93
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $52.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $46.52 | 2019 | |
| Boston Scientific Corporation | $28.05 | 2019 | |
| Abbott Laboratories | $26.90 | 2019-2020 | |
| Allergan, INC. | $24.23 | 2020 | |
| Astellas Pharma US INC | $17.37 | 2019 | |
| Upsher-Smith Laboratories LLC | $14.08 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.06 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.82 | 2019 | |
| Lilly USA, LLC | $11.73 | 2019 | |
| Merck Sharp & Dohme LLC | $11.73 | 2019 | |
| Dynavax Technologies Corporation | $10.44 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.